The viral clearance in interferon-treated chronic hepatitis C is associated with increased cytotoxic T cell frequencies

Journal of Hepatology

Volumn 31, Issue 3, 1999, Pages 407-415

  Löhr, Hanns F ^a   Schmitz, Daniel ^a   Arenz, Monika ^a   Weyer, Sandra ^a   Gerken, Guido ^a   Büschenfelde, Karl Hermann Meyer zum ^a  

^a JOHANNES GUTENBERG UNIVERSITY   (Germany)

Author keywords

Cellular immune response; CTL frequency analysis; Cytotoxic T cells; ELISPOT; Hepatitis C virus; Interferon ; Viral clearance

Indexed keywords

CD8 ANTIGEN; HLA A2 ANTIGEN; HLA ANTIGEN CLASS 1; INTERFERON;

ANTIGEN EXPRESSION; ANTIVIRAL ACTIVITY; ARTICLE; CHRONIC HEPATITIS; CLINICAL ARTICLE; CYTOTOXIC T LYMPHOCYTE; ENZYME LINKED IMMUNOSORBENT ASSAY; HEPATITIS C; HUMAN; IMMUNOTHERAPY; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION; TREATMENT OUTCOME; VIREMIA; VIRUS LOAD;

EID: 0033198353     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-8278(99)80030-0     Document Type: Article

References (36)

1. Houghton M, Weiner A, Han J, Kuo G, Choo Q-L. Molecular biology of the hepatitis C viruses: implications for diagnosis, development and control of disease. Hepatology. 14:1991;381-388.
2. Botarelli P, Brunetto MR, Minutello MA, Calvo P, Unutmaz D, Weiner AJ, et al. T-lymphocyte response to hepatitis C virus in different clinical courses of infection. Gastroenterology. 104:1993;580-587.
3. Ferrari C, Valli A, Galati L, Penna A, Scaccaglia P, Giuberti T, et al. T-cell response to structural and nonstructural hepatitis C virus antigens in persistent and self-limited hepatitis C virus infections. Hepatology. 19:1994;286-295.
4. Löhr HF, Schlaak JF, Kollmannsperger S, Dienes HP, Meyer zum Büschenfelde KH, Gerken G. Liver-infiltrating and circulating CD4+ T cells in chronic hepatitis C: immunodominant epitopes, HLA-restriction and functional significance. Liver. 16:1996;174-182.
5. Minutello MA, Pileri P, Unutmaz D, Censini S, Kuo G, Houghton M, et al. Compartmentalization of T lymphocytes to the site of disease: intrahepatic CD4+ T cells specific for the protein NS4 of hepatitis C virus in patients with chronic hepatitis C. J Exp Med. 178:1993;17-25.
6. Zinkernagel RM, Doherty PC. MHC-restricted cytotoxic T cells. Studies on the biological role of polymorphic major transplantation antigens determining T-cell restriction-specificity. Adv Immunol. 19:1979;51-74.
7. Lasarte J-J, Sarobe P, Gullon A, Prieto J, Borras-Cuesta F. Induction of cytotoxic T lymphocytes in mice against the principal neutralizing domain of HIV-1 by immunisation with an engineered T-cytotoxic-T-helper synthetic peptide construct. Cell Immunol. 141:1996;211-218.
8. Kita H, Moriyama T, Kaneko T, Hiroishi K, Harase I, Miura H, et al. A helper T-cell antigen enhances generation of hepatitis C virus-specific cytotoxic T lymphocytes in vitro. J Med Virol. 45:1995;386-391.
9. Chisari FV. Cytotoxic T cells and viral hepatitis. J Clin Invest. 99:1997;1472-1477.
10. Battegay M, Fikes J, Di Bisceglie AM, Wentworth PA, Sette A, Celis E, et al. Patients with chronic hepatitis C have circulating cytotoxic T cells which recognize hepatitis C virus-encoded peptides binding to HLA-A2.1 molecules. J Virol. 69:1995;2462-2470.
11. Cerny A, McHutchison JG, Pasquinelli C, Brown ME, Brothers MA, Grabscheid B, et al. Cytotoxic T lymphocyte response to hepatitis C virus-derived peptides containing the HLA A2.1 binding motif. J Clin Invest. 95:1995;521-530.
12. Koziel MJ, Dudley D, Afdhal N, Choo QL, Houghton M, Ralston R, et al. Hepatitis C virus (HCV)-specific cytotoxic T lymphocytes recognize epitopes in the core and envelope proteins of HCV. J Virol. 67:1993;7522-7532.
13. Koziel MJ, Dudley D, Afdhal N, Grakoui A, Rice CM, Choo QL, et al. HLA class I-restricted cytotoxic T lymphocytes specific for hepatitis C virus. Identification of multiple epitopes and characterization of patterns of cytokine release. J Clin Invest. 96:1995;2311-2321.
14. Shirai M, Arichi T, Nishioka M, Nomura T, Ikeda K, Kawanishi K, et al. CTL responses of HLA-A2.1-transgenic mice specific for hepatitis C viral peptides predict epitopes for CTL of humans carrying HLA-A2.1. J Immunol. 154:1995;2733-2742.
15. Rehermann B, Chang KM, McHutchison JG, Kokka R, Houghton M, Chisari FV. Quantitative analysis of the peripheral blood cytotoxic T lymphocyte response in patients with chronic hepatitis C virus infection. J Clin Invest. 98:1996;1432-1440.
16. Choo QL, Richman KH, Han JH, Berger K, Lee C, Dong C, et al. Genetic organization and diversity of the hepatitis C virus. Proc Natl Acad Sci USA. 88:1991;2451-2455.
17. Falk K, Rötzschke O, Stevanovic S, Jung G, Rammensee H-G. Allele-specific motifs revealed by sequencing of self-peptides eluted from MHC molecules. Nature. 351:1991;290-295.
18. Herr W, Schneider J, Lohse AW, Meyer zum Büschenfelde K-H, Wölfel T. Detection and quantification of blood-derived CD8+ lymphocytes secreting tumor necrosis factor alpha in response to HLA-A2.1-binding melanoma and viral peptide antigens. J Immunol Meth. 191:1996;131-146.
19. Salter RD, Howell DN, Cresswell P. Genes regulating HLA class I antigen expression in T-B lymphoblast hybrids. Immunogenetics. 21:1995;235-244.
20. Cerundolo V, Alexander J, Anderson K, Lamb C, Cresswell P, Mc Michael A, et al. Presentation of viral antigen controlled by a gene in the major histocompatibility complex. Nature. 345:1990;449-454.
21. Herr W, Linn B, Leister N, Wandel E, Meyer zum Büschenfelde K-H, Wölfel T. The use of computer-assisted video image analysis for the quantification of CD8+ T lymphocytes producing tumor necrosis factor alpha spots in response to peptide antigens. J Immunol Meth. 203:1997;141-152.
22. Löhr HF, Krug S, Herr W, Weyer S, Schlaak J, Wölfel T, et al. Quantitative and functional analysis of core-specific T helper cell and CTL activities in acute and chronic hepatitis B. Liver. 18:1998;405-413.
23. Gerken G, Knolle P, Jakobs S, Meyer zum Büschenfelde K-H. Quantification and genotyping of serum HCV-RNA in patients with chronic hepatitis C undergoing interferon treatment. Arch Virol. 142:1997;459-464.
24. Stuyver L, Rossau R, Wyseur A, Dzuhamel LM, Vanderborght B, van Heuverswyn H, et al. Typing of hepatitis C virus isolates and characterisation of new subtypes using a line probe assay. J Gen Virol. 74:1993;1105-1113.
25. Nelson DR, Marousis CG, Davis GL, Rice CM, Wong J, Houghton M, et al. The role of hepatitis C virus-specific cytotoxic T lymphocytes in chronic hepatitis C. J Immunol. 158:1997;1473-1481.
26. Lalvani A, Brookes R, Hambleton S, Britton WJ, Hill A, Mcmichael AJ. Rapid effector function in CD8+ memory T cells. J Exp Med. 186:1997;859-865.
27. Murali-Krishna K, Altman JD, Suresh M, Sourdive DJD, Zajac AJ, Miller JD, et al. Counting antigen-specific CD8 T cells: a reevaluation of bystander activation during viral infection. Immunity. 8:1998;177-187.
28. Appasamy R, Bryant J, Hassanein T, Van Thiel DH, Whiteside TL. Effects of therapy with interferon-alpha on peripheral blood lymphocyte subsets and NK activity in patients with chronic hepatitis C. Clin Immunol Immunopathol. 73:1994;350-357.
29. Picciotto A, Campo N, Brizzolara R, Sinelli N, Poggi G, Grasso S, et al. HCV-RNA levelsplay an important role independently of genotype in predicting response to interferon therapy. Eur J Gastroenterol Hepatol. 9:1997;67-69.
30. Diepolder HM, Zachoval R, Hoffmann RM, Wierenga EA, Santantonio T, Jung MC, et al. Possible mechanism involving T-lymphocyte response to non-structural protein 3 in viral clearance in acute hepatitis C virus infection. Lancet. 346:1995;1006-1007.
31. Guidotti LG, Ishikawa T, Hobbs MV, Matzke B, Schreiber R, Chisari FV. Intracellular inactivation of the hepatitis B virus by cytotoxic T lymphocytes. Immunity. 4:1996;35-36.
32. Artini M, Nisini R, Missale G, Costanzo A, Accapezzato D, Balsano C, et al. Infection of circulating and liver infiltrating T cells by hepatitis C virus of different subtypes. Viral Immunol. 8:1995;63-73.
33. Fernandez I, Castellano G, Domingo MJ, Fuertes A, Colina F, Canga F, et al. Influence of viral genotype and level of viremia on the severity of liver injury and the response to interferon therapy in Spanish patients with chronic C infection. Scand J Gastroenterol. 32:1997;70-76.
34. Hayashi J, Kishihara Y, Yamaji K, Furusyo N, Yamamoto T, Pae Y, et al. Hepatitis C viral quasispecies and liver damage in patients with chronic hepatitis C virus infection. Hepatology. 25:1997;697-701.
35. Bertoletti A, Sette A, Chisari FV, Ferrari C. Natural variants of cytotoxic epitopes are T-cell receptor antagonists for antiviral cytotoxic T cells. Nature. 369:1994;407-410.
36. Weiner AJ, Erickson AL, Kansopon J, Crawford K, Muchmore E, Houghton M, et al. Association of cytotoxic T lymphocyte (CTL) escape mutations with persistent hepatitis C virus (HCV) infection. Princess Takamatsu Symp. 25:1995;227-235.